205 related articles for article (PubMed ID: 21720428)
1. Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children.
Prats-Puig A; Bassols J; Bargalló E; Mas-Parareda M; Ribot R; Soriano-Rodríguez P; Berengüí À; Díaz M; de Zegher F; Ibánez L; López-Bermejo A
Obesity (Silver Spring); 2011 Sep; 19(9):1905-7. PubMed ID: 21720428
[TBL] [Abstract][Full Text] [Related]
2. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus.
Yan P; Liu D; Long M; Ren Y; Pang J; Li R
Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):257-63. PubMed ID: 21374544
[TBL] [Abstract][Full Text] [Related]
3. Low omentin-1 levels are related with clinical and metabolic parameters in obese children.
Catli G; Anik A; Abaci A; Kume T; Bober E
Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):595-600. PubMed ID: 24085389
[TBL] [Abstract][Full Text] [Related]
4. Relative hypoadiponectinemia, insulin resistance, and increased visceral fat in euthyroid prepubertal girls with low-normal serum free thyroxine.
Prats-Puig A; Sitjar C; Ribot R; Calvo M; Clausell-Pomés N; Soler-Roca M; Soriano-Rodríguez P; Osiniri I; Ros-Miquel M; Bassols J; de Zegher F; Ibáñez L; López-Bermejo A
Obesity (Silver Spring); 2012 Jul; 20(7):1455-61. PubMed ID: 21738234
[TBL] [Abstract][Full Text] [Related]
5. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
6. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
7. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome.
Orlik B; Madej P; Owczarek A; Skałba P; Chudek J; Olszanecka-Glinianowicz M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):529-35. PubMed ID: 24392647
[TBL] [Abstract][Full Text] [Related]
8. The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels.
Akbarzadeh S; Nabipour I; Assadi M; Movahed A; Jafari SM; Motamed N; Nazem H; Haraghy M; Pourbehi A; Bargahi A; Hajian N
Cytokine; 2012 May; 58(2):295-9. PubMed ID: 22398372
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study.
Herder C; Ouwens DM; Carstensen M; Kowall B; Huth C; Meisinger C; Rathmann W; Roden M; Thorand B
Eur J Endocrinol; 2015 Apr; 172(4):423-32. PubMed ID: 25733068
[TBL] [Abstract][Full Text] [Related]
10. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men.
Saremi A; Asghari M; Ghorbani A
J Sports Sci; 2010 Jul; 28(9):993-8. PubMed ID: 20544489
[TBL] [Abstract][Full Text] [Related]
11. The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity.
Zehsaz F; Farhangi N; Ghahramani M
Phys Sportsmed; 2016 Nov; 44(4):355-361. PubMed ID: 27737602
[TBL] [Abstract][Full Text] [Related]
12. Omentin plasma levels and gene expression are decreased in obesity.
de Souza Batista CM; Yang RZ; Lee MJ; Glynn NM; Yu DZ; Pray J; Ndubuizu K; Patil S; Schwartz A; Kligman M; Fried SK; Gong DW; Shuldiner AR; Pollin TI; McLenithan JC
Diabetes; 2007 Jun; 56(6):1655-61. PubMed ID: 17329619
[TBL] [Abstract][Full Text] [Related]
13. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
14. Link between omentin-1, obesity and insulin resistance in children: Findings from a longitudinal intervention study.
Rothermel J; Lass N; Barth A; Reinehr T
Pediatr Obes; 2020 May; 15(5):e12605. PubMed ID: 31840425
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
17. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children.
Ogawa Y; Kikuchi T; Nagasaki K; Hiura M; Tanaka Y; Uchiyama M
Hypertens Res; 2005 Jan; 28(1):51-7. PubMed ID: 15969255
[TBL] [Abstract][Full Text] [Related]
19. Effect of High-Intensity Interval Training on Plasma Omentin-1 Concentration in Overweight/Obese and Normal-Weight Youth.
Ouerghi N; Ben Fradj MK; Bezrati I; Feki M; Kaabachi N; Bouassida A
Obes Facts; 2017; 10(4):323-331. PubMed ID: 28787708
[TBL] [Abstract][Full Text] [Related]
20. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.
Pan HY; Guo L; Li Q
Diabetes Res Clin Pract; 2010 Apr; 88(1):29-33. PubMed ID: 20129687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
